These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 3337615

  • 1. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 3. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
    Hollander E, DeCaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR.
    Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
    [Abstract] [Full Text] [Related]

  • 5. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS, Westenberg HG.
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [Abstract] [Full Text] [Related]

  • 6. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 7. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 8. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS.
    Arch Gen Psychiatry; 1993 Aug 01; 50(8):624-35. PubMed ID: 8102048
    [Abstract] [Full Text] [Related]

  • 9. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC, Goodman WK, Price LH.
    Int Clin Psychopharmacol; 1993 Nov 01; 8 Suppl 2():79-82. PubMed ID: 8201248
    [Abstract] [Full Text] [Related]

  • 10. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
    Charney DS, Woods SW, Goodman WK, Heninger GR.
    Psychopharmacology (Berl); 1987 Nov 01; 92(1):14-24. PubMed ID: 3110824
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
    Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J.
    Neuropsychobiology; 2004 Nov 01; 50(3):200-5. PubMed ID: 15365215
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
    Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL.
    Arch Gen Psychiatry; 1987 Nov 01; 44(11):946-51. PubMed ID: 3675134
    [Abstract] [Full Text] [Related]

  • 13. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH.
    Am J Psychiatry; 1994 Nov 01; 151(11):1626-30. PubMed ID: 7943451
    [Abstract] [Full Text] [Related]

  • 14. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR.
    Biol Psychiatry; 1995 Aug 01; 38(3):138-49. PubMed ID: 7578657
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC.
    Arch Gen Psychiatry; 1992 Nov 01; 49(11):852-61. PubMed ID: 1444722
    [Abstract] [Full Text] [Related]

  • 16. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M.
    Psychiatry Res; 1992 Jul 01; 43(1):1-12. PubMed ID: 1332094
    [Abstract] [Full Text] [Related]

  • 17. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls.
    Lesch KP, Hoh A, Disselkamp-Tietze J, Wiesmann M, Osterheider M, Schulte HM.
    Arch Gen Psychiatry; 1991 Jun 01; 48(6):540-7. PubMed ID: 1674853
    [Abstract] [Full Text] [Related]

  • 18. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Int Clin Psychopharmacol; 1992 Jun 01; 7(1):45-9. PubMed ID: 1624756
    [Abstract] [Full Text] [Related]

  • 19. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
    Bastani B, Nash JF, Meltzer HY.
    Arch Gen Psychiatry; 1990 Sep 01; 47(9):833-9. PubMed ID: 2203327
    [Abstract] [Full Text] [Related]

  • 20. Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder.
    Fineberg NA, Cowen PJ, Kirk JW, Montgomery SA.
    J Affect Disord; 1994 Oct 01; 32(2):97-104. PubMed ID: 7829769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.